Acute effects of LI 160 (extract of Hypericum perforatum,St John's wort) and two of its constituents on neuroendocrine responses in the rat

Abstract

Extracts of Hypericum perforatum (St John's wort), such as LI 160, which are effective antidepressants have several active constituents. Their mode of action in depression, however, is unclear. In the present investigation, we assessed the effect of equivalent doses of LI 160 and two of its components, hypericin and hyperforin on serotonin (5-HT) and dopamine (DA)-mediated neuroendocrine responses in the rat. LI 160, hypericin and hyperforin significantly and equivalently increased plasma corticosterone. This effect was blocked by ketanserin but not WAY-100635, suggesting mediation via 5-HT2 receptors. LI 160 also lowered plasma prolactin and prevented the increase in plasma prolactin following haloperidol administration. Hyperforin had a similar but somewhat less pronounced effect. We conclude that LI 160, hypericin and hyperforin all increase 5-HT-mediated corticosterone release while LI 160 enhances DA-mediated inhibition of prolactin release. Hyperforin may contribute to the facilitatory effect of LI 160 on DA function, but hypericin does not.

Keywords

corticosterone dopamine hypericin hyperforin hypericum LI 160 prolactin serotonin

Get full access to this article

View all access options for this article.

References

Butterweck V , Nahrstedt A , Winterhoff H (1998) Effects of hypericum perforatun extract and isolated constituents on neruotransmitter concentrations and endocrine parameters. 46th Annual Congress of the Society for Medicinal Plant Research, Vienna, Austria

Calapai G , Crupi A , Firenzuoli F , Constantino G , Interreria G , Campo G M , Caput A (1999) Effects of hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline, dopamine in the cortex, diencephalon and brain stem of rats. J Pharm Pharmacol 51: 723–728

Chi J , Odontiadis J , Franklin M (1999) Simultaneous determination of catecholamines in rat brain tissue by high performance liquid chromatography. J Chromatogr B 731: 361–367

Di Matteo V , Giovanni G , Di Mascio M , Esposito E (2000) Effect of acute administration of hypericum-CO2 extract on dopamine and serotonin release in the rat CNS. Pharmacopsychiatry 33: 14–18

Franklin M , Chi J , McGavin C , Hockney R , Reed A , Campling G , Whale R W R , Cowen P J (1999) Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers. Biol Psychiatry 46: 381–384

Kaehler S T , Sinner C , Chatterjee S S , Philippu A (1999) Hyperforin enhances serotonin and glutamate in the rat locus ceoruleus. Neurosci Lett 262: 199–202

King B H , Brazell C , Dourish C T , Middlemiss D N (1989) Activation of the 5-HT2 receptor sub-type increases rat plasma ACTH concentration. Br J Pharmacol 98: 686–690

Laakman G , Schule C , Dienel A (2000) Effects of hypericum extract on adenohypophysial hormone secretion and catecholamine metabolism. Proceedings of the Biocenter Symposium on Drug Therapy. Pharmacology of St John's wort (Hypericum perforatum L.) and its constituents. University of Frankfurt, Germany

Linde K , Ramirez G , Mulrow C D , Pauls A , Weidenhammer W , Melchart D (1996) St John's wort for depression an overview and meta-analysis of randomised clinical trials. BMJ 313: 253–258

10.

Muller W E , Rolli M , Schaffer C , Hafner U (1997) Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 30: 102–107

11.

Muller W E , Singer A , Wonnermann M , Hafner U , Rolli M , Schafer C (1998) Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 31: 16–21

12.

Nahrstedt A , Butterweck V (1997) Biologically active and other chemical constituents of the herb Hypericum perforatum L. Pharmacopsyciatry 30: 129–134

13.

Teufel-Mayer R , Gleitz J (1997) Effects of log-term administration of hypericum extracts on the affinity and density of the central 5-HT1A and 5-HT2A receptors. Pharmacopsychiatry 30: 113–116

14.

Volz H P (1997) Hypericum: an overview of published therapeutic trials. Pharmacopsychiatry 30: 72–76

15.

Wonnermann M , Singer B , Siebert B , Muller W E (2000) Synaptosomal uptake inhibition by oligomeric procyanidines (OPC) of St John's wort invitro. Proceedings of the Biocenter Symposium on Drug Therapy. Pharmacology of St John's wort (Hypericum perforatum L.) and its constituents. University of Frankfurt, Germany

16.

Yu H (2000) Effect of hypericum perforatum extract on serotonin turnover in mouse brain. Proceedings of the Biocenter Symposium on Drug Therapy. Pharmacology of St John's wort (Hypericum perforatum L.) and its constituents. University of Frankfurt, Germany